In October, due to demand from existing healthcare partners, CTS began testing blood donors for antibody to Babesia microti under an Investigational New Drug exemption as a release test.
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...